Citation: J. Janson et al., HIGH ISLET AMYLOID POLYPEPTIDE SECRETION RESULTS IN TRANSIENT HYPERGLYCEMIA WITHOUT BETA-CELL DEATH, Diabetes, 47, 1998, pp. 116-116
Citation: J. Janson et al., HIGH ISLET AMYLOID POLYPEPTIDE SECRETION RESULTS IN TRANSIENT HYPERGLYCEMIA WITHOUT BETA-CELL DEATH, Diabetes, 47, 1998, pp. 300-300
Authors:
COUCE M
KANE LA
OBRIEN TD
CHARLESWORTH J
SOELLER W
MCNEISH J
KREUTTER D
ROCHE P
BUTLER PC
Citation: M. Couce et al., TREATMENT WITH GROWTH-HORMONE AND DEXAMETHASONE IN MICE TRANSGENIC FOR HUMAN ISLET AMYLOID POLYPEPTIDE CAUSES ISLET AMYLOIDOSIS AND BETA-CELL DYSFUNCTION, Diabetes, 45(8), 1996, pp. 1094-1101
Authors:
COUCE M
KANE LA
OBRIEN TD
SOELLER W
MCNEISH J
KREUTTER D
ROCHE P
BUTLER PC
Citation: M. Couce et al., INDUCTION OF INSULIN-RESISTANCE IN MICE TRANSGENIC FOR HUMAN ISLET AMYLOID POLYPEPTIDE CAUSES ISLET AMYLOIDOSIS AND BETA-CELL DYSFUNCTION, Diabetes, 45, 1996, pp. 134-134
Citation: M. Carty et al., HUMAN IAPP PROMOTER ACTIVITY IS REGULATED BY SEQUENCES BOT UPSTREAM AND DOWNSTREAM OF THE TRANSCRIPTION INITIATION SITE, Diabetes, 44, 1995, pp. 75-75
Citation: W. Soeller et al., HUMAN AMYLIN PROMOTER ANALYSIS REVEALS REQUIREMENT FOR BOTH EXON AND INTRON SEQUENCES DOWNSTREAM FROM THE TRANSCRIPTION INITIATION SITE, Journal of cellular biochemistry, 1994, pp. 137-137